4HL-92043-66431
3 vaccinations
3 coded responses
35 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 189 / PA
- Registered
- 2021-06-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-22
Registered in v-safe
-
2021-06-22
Dose 1 — Pfizer-BioNTech
- 2021-06-22
- 2021-06-23
- 2021-06-24
- 2021-06-25
- 2021-06-26
- 2021-06-27
-
2021-06-28
Survey response — days 1–6 daily, dose 1MedDRA: Vulvovaginal mycotic infection — Feeling: GoodFree text: Vaginal yeast infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-29
Survey response — day 7, dose 1MedDRA: Fungal infection — Feeling: GoodFree text: Vaginal yeast infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-06
-
2021-07-13
Dose 2 — Pfizer-BioNTech
- 2021-07-13
- 2021-07-14
-
2021-07-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-07-16
- 2021-07-19
- 2021-07-20
- 2021-07-27
- 2021-08-03
- 2021-08-10
- 2021-08-17
- 2021-08-24
- 2021-10-12
-
2022-01-11
Survey response — 6 months, dose 2MedDRA: Premature delivery, Premature rupture of membranes — Feeling: GoodFree text: Premature rupture of membranes (PROM) resulting in pre-term birth of baby at 34 weeks gestation.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Dose 3 — Pfizer-BioNTech
-
2022-01-15
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fever · Chills, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2022-01-16
- 2022-01-17
- 2022-01-18
- 2022-01-19
- 2022-01-22
- 2022-01-27
- 2022-02-03
- 2022-02-10
- 2022-02-17
- 2022-02-24
- 2022-04-14
- 2022-07-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-22 | Pfizer-BioNTech | No |
| 2 | 2021-07-13 | Pfizer-BioNTech | No |
| 3 | 2022-01-13 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Vaginal yeast infection
Release 9 — day 7, dose 1
Systemic reaction (other): Vaginal yeast infection
Release 10 — 6 months, dose 2
Symptoms: Premature rupture of membranes (PROM) resulting in pre-term birth of baby at 34 weeks gestation.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Premature delivery | · | · | ✓ |
| SD | Premature rupture of membranes | · | · | ✓ |
| SRO | Fungal infection | ✓ | ✓ | ✓ |
| SRO | Vulvovaginal mycotic infection | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release